Palo Alto Networks (NASDAQ: PANW) announced a landmark deal with Google Cloud on Dec. 19, aimed at integrating artificial intelligence (AI) into cybersecurity at scale. The agreement, reportedly worth... ...

Key Points IonQ’s rapidly scaling revenue base and contracted backlog are solid positives for the company. D-Wave Quantum’s quantum annealing technology has demonstrated applicability in real-world use cases. Both stocks are trading at extremely rich valuations. 10 stocks we like better than IonQ › Quantum computing is advancing gradually from academic pursuit to early commercialization, and according to the market research firm The Quantum Insider, between now and 2035, the technology could add m ...

ADNOC has received Dh7.34bn ($2bn) in green financing backed by the Korean export credit agency, Korea Trade Insurance Corporation (K-SURE). This financing aims to support lower-carbon projects within ADNOC’s operations. United Arab Emirates (UAE) Minister of Industry and Advanced Technology and ADNOC managing director and group CEO Sultan Al Jaber announced the agreement during his visit to South Korea to meet K-SURE president and chairman Youngjin Jang. ADNOC said that the new financing, structured u ...

President Trump just signed an executive order today reaffirming the U.S. ...

Two years after surviving bankruptcy proceedings, AeroFarms risks going out of business after the US-based vertical-farming company’s main backer decided against further investment. AeroFarms filed a WARN notice with the Department of Workforce Development and Advancement in Virginia earlier in December saying the company plans to close its Ringgold indoor vertical farm in Danville. As a result, 173 jobs would be terminated. In September 2023, the New Jersey-headquartered company said it had exited Chap ...

Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE .The similarities between the late innings of the Internet Boom a quarter century ago and the current state of the rally powered by the AI Revolution are growing more eerily similar by the week.Bret Jensen has over 13 years as a market a ...

Recent inflation data, expectations of a Fed chair appointment favoring rate cuts and comments from Fed Governor Christopher Waller have increased the likelihood of rate cuts beyond what markets may have priced in.According to the CME FedWatch tool, markets are anticipating a 25.5% likelihood of interest rates being lowered to 3.25-3.5% in its January 2026 meeting, up from a 15.3% likelihood just a month earlier.Softer Inflation Fuels Hopes of Earlier Rate CutsSofter U.S. inflation data have strengthened be ...

Cassava Sciences Inc. (NASDAQ:SAVA) received a formal letter from the U.S. Food and Drug Administration (FDA) related to the company’s trial for simufilamFollowing previously reported communications with the FDA regarding Cassava’s investigational new drug application and proposed proof-of-concept clinical trial for simufilam in tuberous sclerosis complex (TSC)-related epilepsy, the company confirmed a full FDA clinical hold.The SEC filing highlighted that the company has to provide the FDA with additional ...

Let's continue the conversation right here with Toron Slack. He's chief economist at Apollo Global Management. Um, you have a favorite in that Fed race, by the way.Well, so I don't have a personal favorite, but I think it's clear that the market is trying to chew hard on which of these candidates will have implications for what's happening, especially of course in rates. What the conclusion of course here is that it all becomes about can the new fetcher persuade the other FOMC members about whatever his vie ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersFXEmpire is owned and operated by Empire Media Network LTD., Company Registration Number 514641786, registered at 7 Jabotinsky Road, Ramat Gan 5252007, Israel. The content provided on this website includes general news and publications, our personal analysis and opinions, and materials provided by third parties. This content is intended for educational and research purposes only. It does not constitute, and should not be interpreted a ...